Abstract
Systemic mastocytosis is a rare condition characterized clinically by the local consequences of vasoactive peptides released from infiltrating mast cells in the reticuloendothelial tissues. Mast cells originate from the pluripotent bone marrow stem cells; it is therefore not surprising that myeloproliferative and myelodysplastic disorders commonly coexist or terminate the clinical phase of mastocytosis. We report here, to our knowledge, the first case of Hodgkin's and Castleman's disease occurring in a patient with co-existent systemic mastocytosis, which remained unchanged after combination chemotherapy for Hodgkin's disease.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: December 18, 1997 / Accepted: September 8, 1998
Rights and permissions
About this article
Cite this article
Saletti, P., Ghielmini, M., Scali, G. et al. Hodgkin's and Castleman's disease in a patient with systemic mastocytosis. Ann Hematol 78, 97–100 (1999). https://doi.org/10.1007/s002770050482
Issue Date:
DOI: https://doi.org/10.1007/s002770050482